APA (7th ed.) Citation

X, L., A, M., R, G. d. S., A, S., D, H., A, S., . . . S, A. (2025). A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer. Cell death & disease, 16(1), 221. https://doi.org/10.1038/s41419-025-07547-7

Chicago Style (17th ed.) Citation

X, Liu, Moamer A, Gomes da Silva R, Shoham-Amizlev A, Hamam D, Shams A, Lebrun JJ, and Ali S. "A Novel Clinically Relevant Antagonistic Interplay Between Prolactin and Oncogenic YAP-CCN2 Pathways as a Differentiation Therapeutic Target in Breast Cancer." Cell Death & Disease 16, no. 1 (2025): 221. https://doi.org/10.1038/s41419-025-07547-7.

MLA (9th ed.) Citation

X, Liu, et al. "A Novel Clinically Relevant Antagonistic Interplay Between Prolactin and Oncogenic YAP-CCN2 Pathways as a Differentiation Therapeutic Target in Breast Cancer." Cell Death & Disease, vol. 16, no. 1, 2025, p. 221, https://doi.org/10.1038/s41419-025-07547-7.